The store will not work correctly when cookies are disabled.
US9428478, TG2-150
ID: ALA3980488
PubChem CID: 18096451
Max Phase: Preclinical
Molecular Formula: C21H25N3O3
Molecular Weight: 367.45
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: COc1ccc(N2CCN(C(=O)CNc3ccc(C(C)=O)cc3)CC2)cc1
Standard InChI: InChI=1S/C21H25N3O3/c1-16(25)17-3-5-18(6-4-17)22-15-21(26)24-13-11-23(12-14-24)19-7-9-20(27-2)10-8-19/h3-10,22H,11-15H2,1-2H3
Standard InChI Key: PDUZMCJPSVQAHF-UHFFFAOYSA-N
Molfile:
RDKit 2D
27 29 0 0 0 0 0 0 0 0999 V2000
2.5956 -2.7031 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.5973 -1.5031 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1.2990 -0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.2990 0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0000 1.5000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.2990 0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.2990 -0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0000 -1.5000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.5987 1.5004 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-2.6012 3.0004 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.9015 3.7484 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-5.1993 2.9963 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-5.1969 1.4963 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.8967 0.7484 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-6.5018 3.7420 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-6.5058 4.9420 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-7.7993 2.9876 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-9.1017 3.7333 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-10.3992 2.9790 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-11.7021 3.7223 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-12.9973 2.9658 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-12.9898 1.4658 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-11.6870 0.7224 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-10.3917 1.4789 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-14.2842 0.7062 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-14.2764 -0.4938 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-15.3274 1.2991 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 7 1 0
7 8 2 0
8 3 1 0
6 9 1 0
9 10 1 0
10 11 1 0
11 12 1 0
12 13 1 0
13 14 1 0
14 9 1 0
12 15 1 0
15 16 2 0
15 17 1 0
17 18 1 0
18 19 1 0
19 20 2 0
20 21 1 0
21 22 2 0
22 23 1 0
23 24 2 0
24 19 1 0
22 25 1 0
25 26 2 0
25 27 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 367.45 | Molecular Weight (Monoisotopic): 367.1896 | AlogP: 2.66 | #Rotatable Bonds: 6 |
Polar Surface Area: 61.88 | Molecular Species: NEUTRAL | HBA: 5 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 6 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: 3.99 | CX LogP: 1.70 | CX LogD: 1.70 |
Aromatic Rings: 2 | Heavy Atoms: 27 | QED Weighted: 0.80 | Np Likeness Score: -1.46 |
References
1. (2016) Piperazine derivatives, compositions, and uses related thereto, |